TODAY'S HEADLINES

New 340B rule sets drugmaker fines

Consumer health groups are praising Health and Human Services' (HHS) new rule on the Medicaid 340B drug discount program, which sets a ceiling on drug prices. Read more

FDA approves hemophilia A drug for children

FDA recently expanded the use of antihemophilic factor (recombinant), pegylated (Adynovate) for hemophilia A patients under 12 years old. Read more

CONTINUING PHARMACY EDUCATION

Key cogs in the management of Parkinson's disease

This month's CE activity, "Key cogs in the management of Parkinson's disease," is open for pharmacists and pharmacy technicians.
The goal of this activity is to assist pharmacists and pharmacy technicians in managing difficult-to-treat symptoms of Parkinson's disease.
Pharmacists and pharmacy technicians can earn up to 2 hours of CPE credit for completing this knowledge-based activity from the University of Connecticut School of Pharmacy and Drug Topics. More

EDITOR'S PICK

Why 2016 drug approvals fell

While FDA approved far fewer new drugs in 2016 than 2015, the agency quickly approved novel and breakthrough therapies. Find out why

January 11, 2017

Related Articles

Medicare drug pricing debate heats up

FDA approves expansion of Avastin in ovarian cancer